Stem Cell Orthopedic Applauds New Study Promoting Platelet Rich Plasma Therapy

Stem Cell Orthopedic Applauds New Study Showing Platelet Rich Plasma Therapy Significantly Improving Clinical Results in Patients with Tennis Elbow.

(PRWEB) April 06, 2013

The analysis, from the Rothman Institute at Jefferson, included a multi-center randomized prospective study to research the clinical value of PRP. The study utilized 230 patients with chronic tennis elbow, where virtually one half was treated with PRP and the other half was the control group. The PRP group received single PRP injections into their extensor tendon.

Both groups were studied for up to 24 weeks. By week 12, the PRP group reported a 55% improvement in pain, versus 47% for the control group. Concurrently, at week 12, the PRP group reported 37.4% significant elbow tenderness, compared to 48% from the control group. By the end of 24 weeks, the PRP group reported an outstanding 29% significant tenderness rating, versus 54% from the control.

The results of this study present some of the most compelling evidence to date of the efficacy of platelet rich plasma therapy and its significance in the medical community at large.

The study was recently presented at the annual meeting of the American Association of Orthopedic Surgeons (AAOS) in Chicago.

As leading stem cell treatment practitioners, the Institute of Regenerative and Molecular Orthopaedics applauds the findings of this latest PRP therapy study. Headed by the world-renowned stem cell treatment pioneer, Dr. Joseph Purita, the IRMO are one of the very few orthopedic practices in the world that utilizes PRP stem cell therapy with orthopedic surgery.

About Stem Cell Orthopedic

The Institute of Regenerative and Molecular Orthopaedics (IRMO) is a world-class orthopedic practice and stem cell facility staffed with seasoned board certified orthopedic surgeons. They differ from most orthopedic practices because they offer stem cells and platelet rich plasma (PRP) therapy in conjunction with surgery or as alternative to surgical procedures. They utilize state-of-the-art technology and the latest in stem cell research to best treat their patients. IRMO uses hematopoietic stem cells (HSC), which are found circulating in blood, fat, and bone marrow, to help repair the body. They are headed by Medical Director, Dr. Joseph Purita, a world-renowned pioneer in laser orthopedic surgery and graduate of the esteemed Georgetown University Medical School. For more information, visit or follow them on Facebook, Twitter, or YouTube.

Contact Us IRMO 561-300-1840 Email Information

Continued here:
Stem Cell Orthopedic Applauds New Study Promoting Platelet Rich Plasma Therapy

Related Post